Since 2010, there has been an increasing number of adverse analytical findings related to selective androgen receptor modulators (SARMs) in competitive sports. It emphasizes the importance of comprehensive doping control analytical procedures that are capable of detecting SARM misuse.Methods: In this study, it is described how LY2452473, a SARM, was metabolized in thoroughbred horses after a single-dose oral administration and in vitro with equine liver microsome preparations. An investigation of the metabolism of LY2452473 in horses' urine, plasma, and hair matrices was carried out during the study. The plausible structures of the detected metabolites were postulated using highperformance liquid chromatography-high resolution mass spectrometry.Results: Under the experimental conditions 15 metabolites (12 phase I and three conjugates of phase I) were detected (M1-M15). The major phase I metabolites identified were formed by hydroxylation. Side-chain dissociated and methylated metabolites were also detected. In phase II, the glucuronic acid and sulfonic acid conjugates of hydroxy LY2452473 were detected as the major metabolites. In vitro analysis has confirmed the presence of all metabolites found in vivo except for the methylated analogs M11 and M12. A peak concentration of LY2452473 (0.5 pg/mg) in proximal hair segments was achieved 4 weeks after administration, according to hair analysis.Conclusions: Data obtained will aid in identifying LY2452473 and related substances faster. Furthermore, the results will assist in checking for the illegal use of these substances in competitive sports.
| INTRODUCTIONThe role of androgens in male sexual development and maintenance cannot be overstated. 1 Androgens are predominant in male reproductive organs, but also moderately expressed in female genitalia and ovaries, as well as in skin, sebaceous glands, sweat glands, hair follicles, cardiac muscles, skeletal muscles, and brain. 2 A risk of serious side effects, such as prostate cancer development and progression, has limited the use of steroidal androgens. [3][4][5] Selective androgen receptor modulators (SARMs) are tissue-specific to anabolic target tissues (muscle and bone) and do not have the side effects associated with conventional androgens. The basic idea of the SARMs is that they modulate the transcriptional activity of the androgen receptor in a tissue-selective fashion. These compounds are agonistic in their effects on target tissues such as muscle and bone, but weak in their effects on reproductive organs (prostate). The molecular